{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:02:10Z","timestamp":1784869330751,"version":"3.55.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fertility-sparing treatment (FST) is an accepted option for selected women with endometrial carcinoma (EC) or atypical endometrial hyperplasia (AEH) wishing to preserve fertility. However, the impact of FST on subsequent endometrial function remains poorly understood. Oocyte donation (OD) offers a unique model to evaluate endometrial receptivity independently of oocyte quality. We assessed reproductive outcomes after OD in women aged \u226540 years with a history of FST for EC or AEH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective case series included women aged \u226540 years with histologically confirmed Endometrioid endometrial carcinoma (EEC) or AEH who achieved complete response after FST and subsequently underwent blastocyst transfer through OD. All cycles involved vitrified-warmed donor oocytes, intracytoplasmic sperm injection, blastocyst culture, and elective single embryo transfer. The primary outcome was live birth rate (LBR) per embryo transfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixteen patients underwent 27 embryo transfer cycles. Median age at first transfer was 45.5 years. Embryological outcomes were excellent, with a 96.8% oocyte survival rate and 80.4% top-quality blastocysts. Despite adequate endometrial preparation in all cases, reproductive outcomes were poor. The cumulative LBR per embryo transfer was 18.5% (5\/27), while the cumulative LBR per patient was 31.2% (5\/16). Patients with disease recurrence showed lower live birth rates than those without recurrence. Endometrial thickness was not associated with implantation outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Women aged \u226540 years undergoing OD after FST for EC or AEH experience reduced reproductive success despite optimal embryo quality. These findings are consistent with the hypothesis of persistent endometrial dysfunction after FST and highlight the need for improved assessment of endometrial receptivity and timely integration of assisted reproductive treatment following complete response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1897240","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:13Z","timestamp":1784867053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistent endometrial dysfunction after fertility-sparing treatment for endometrial carcinoma: insights from donor oocyte cycles"],"prefix":"10.3389","volume":"16","author":[{"given":"Pierfrancesco","family":"Greco","sequence":"first","affiliation":[{"name":"Centre for Reproductive Medicine, Villa Mafalda","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanno","family":"Greco","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Villa Mafalda","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Varricchio","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Villa Mafalda","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Maria","family":"Ianieri","sequence":"additional","affiliation":[{"name":"Unit of Gynecology and Obstetrics, Policlinico Abano Terme","place":["Abano Terme, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Masciullo","sequence":"additional","affiliation":[{"name":"Division of Gynecological Surgery, Department of Women\u2019s and Children\u2019s Health, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Costanzi","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Villa Mafalda","place":["Rome, Italy"]},{"name":"Surgical and Medical Sciences and Translational Medicine, Sant\u2019Andrea Hospital, Sapienza University of Rome","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of endometrial hyperplasia","volume":"200","author":"Reed","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2024.09.030","article-title":"Risk factors for atypical hyperplasia or endometrial cancer in premenopausal women aged \u226445 years with abnormal uterine bleeding","volume":"302","author":"Jang","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101780","article-title":"Endometrial hyperplasia in infertile women undergoing IVF\/ICSI: a retrospective cross-sectional study","volume":"49","author":"Tian","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010112","article-title":"Fertility sparing in endometrial cancer: where are we now","volume":"17","author":"Centini","year":"2025","journal-title":"Cancers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215187","article-title":"Endometrial cancer in reproductive age: fertility-sparing approach and reproductive outcomes","volume":"14","author":"Mutlu","year":"2022","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18030399","article-title":"Oncologic and reproductive outcomes of fertility-sparing management in early-stage endometrial carcinoma: a systematic review and meta-analysis","volume":"18","author":"Sebok","year":"2026","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmab041","article-title":"Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis","volume":"28","author":"Cappelletti","year":"2022","journal-title":"Hum Reprod Update"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmad019","article-title":"Endometrial receptivity in women of advanced age: an underrated factor in infertility","volume":"29","author":"Pathare","year":"2023","journal-title":"Hum Reprod Update"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae048","article-title":"Aging promotes accumulation of senescent and multiciliated cells in human endometrial epithelium","volume":"2024","author":"Loid","year":"2024","journal-title":"Hum Reprod Open"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.08.933","article-title":"The association between advanced maternal age and abnormal endometrial receptivity in donor-egg IVF pregnancy outcomes","volume":"120","author":"Duster","year":"2023","journal-title":"Fertil Steril"},{"key":"B14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12958-024-01323-6","article-title":"Age-related uterine changes and its association with poor reproductive outcomes: a systematic review and meta-analysis","volume":"22","author":"Marti-Garcia","year":"2024","journal-title":"Reprod Biol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2020.06.006","article-title":"The impact of advanced maternal age on pregnancy outcome","volume":"70","author":"Attali","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5935\/1518-0557.20220000","article-title":"In vitro fertilisation and intracytoplasmic sperm injection predictive factors: a review of the effect of female age, ovarian reserve, male age, and male factor on IVF\/ICSI treatment outcomes","volume":"27","author":"Ribeiro","year":"2022","journal-title":"Jbra Assist Reprod"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/biom14030306","article-title":"Reproductive and oncologic outcomes in young women with stage IA and grade 2 endometrial carcinoma undergoing fertility-sparing treatment: a systematic review","volume":"14","author":"Etrusco","year":"2024","journal-title":"Biomolecules"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.07.018","article-title":"Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis","volume":"231","author":"Suzuki","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2026.104565","article-title":"Fertility and obstetric outcomes after fertility-sparing treatment for early-stage endometrial cancer and atypical hyperplasia: a systematic review and meta-analysis","volume":"36","author":"Yang","year":"2026","journal-title":"Int J Gynecol Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14923","article-title":"Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac057","article-title":"ESGO\/ESHRE\/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"2023","author":"Rodolakis","year":"2023","journal-title":"Hum Reprod Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14646","article-title":"Conservative management of grade 2 stage IA endometrial carcinoma and literature review","volume":"47","author":"Shan","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/life11121368","article-title":"The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis","volume":"11","author":"Boitrelle","year":"2021","journal-title":"Life"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-199906000-00013","article-title":"Culture and transfer of human blastocysts","volume":"11","author":"Gardner","year":"1999","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.104291","article-title":"IVF and obstetric outcomes among women of advanced maternal age (\u226545 years) using donor eggs","volume":"49","author":"Chen","year":"2024","journal-title":"Reprod BioMed Online"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072123","article-title":"Fertility-sparing treatment and assisted reproductive technology in patients with endometrial carcinoma and endometrial hyperplasia: pregnancy outcomes after embryo transfer","volume":"15","author":"Friedlander","year":"2023","journal-title":"Cancers"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2025.36.e111","article-title":"Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment","volume":"36","author":"Cheng","year":"2025","journal-title":"J Gynecol Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000005824","article-title":"Risk of placenta accreta spectrum disorder after prior non-cesarean delivery uterine surgery","volume":"145","author":"Yang","year":"2025","journal-title":"Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15493","article-title":"Risk factors for placenta accreta spectrum without prior cesarean section: a case-control study in China","volume":"166","author":"You","year":"2024","journal-title":"Int J Gynecol Obstet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12884-022-05164-2","article-title":"The link between intrauterine adhesions and impaired reproductive performance: a systematic review of the literature","volume":"22","author":"Hooker","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738370","article-title":"Management of recurrent endometrial cancer or atypical endometrial hyperplasia patients after primary fertility-sparing therapy","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.70139","article-title":"Is it safe to preserve uterus after live birth following progestin-based fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a long-term retrospective cohort study","volume":"105","author":"Wang","year":"2026","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12958-021-00808-y","article-title":"Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia","volume":"19","author":"Fan","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2021.06.007","article-title":"IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management","volume":"43","author":"Vaugon","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040563","article-title":"HOXA10 and HOXA11 in human endometrial benign disorders: unraveling molecular pathways and their impact on reproduction","volume":"15","author":"P\u00eerlog","year":"2025","journal-title":"Biomolecules"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0328871","article-title":"Effects of standard and low doses of estradiol on markers of endometrial receptivity in frozen-thawed embryo transfer cycles: double-blind, randomized clinical trial","volume":"20","author":"Parkpinyo","year":"2025","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-015-0136-7","article-title":"Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia","volume":"14","author":"Inoue","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e35","article-title":"Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients","volume":"29","author":"Yang","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.812346","article-title":"Fertility-sparing treatment for endometrial cancer or atypical endometrial hyperplasia patients with obesity","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2021.32.e70","article-title":"Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome","volume":"32","author":"Wang","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205024","article-title":"Effects of weight status and related metabolic disorders on fertility-sparing treatment outcomes in endometrial atypical hyperplasia and endometrial cancer: a retrospective study","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12958-022-01006-0","article-title":"Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients","volume":"20","author":"Ding","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003721","article-title":"Fertility-preserving treatment of endometrial cancer and endometrial atypical hyperplasia for patients with metabolic abnormalities: challenge or opportunity","volume":"139","author":"Bo","year":"2025","journal-title":"Chin Med J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18050839","article-title":"Oncological and reproductive outcomes of a standardized hysteroscopic approach for the fertility-sparing treatment of atypical endometrial hyperplasia and early-stage endometrial cancer","volume":"18","author":"Catena","year":"2026","journal-title":"Cancers"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae089","article-title":"Pregnancy and obstetric outcomes after fertility-sparing management of endometrial cancer and atypical hyperplasia: a multicentre cohort study","volume":"39","author":"Vasileva","year":"2024","journal-title":"Hum Reprod"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.01.001","article-title":"Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer","volume":"161","author":"Novikova","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092170","article-title":"Fertility-sparing treatment for endometrial cancer: oncological and obstetric outcomes in combined therapies with levonorgestrel intrauterine device","volume":"14","author":"Pino","year":"2022","journal-title":"Cancers"},{"key":"B49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ijgo.15898","article-title":"Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early-stage endometrial cancer after fertility-sparing treatment","volume":"168","author":"Li","year":"2024","journal-title":"Int J Gynecol Obstet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/ijgc-2018-000081","article-title":"Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia","volume":"29","author":"Wang","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e38","article-title":"Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan","volume":"34","author":"Ushijima","year":"2023","journal-title":"J Gynecol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1897240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:14Z","timestamp":1784867054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1897240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":51,"alternative-id":["10.3389\/fonc.2026.1897240"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1897240","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"1897240"}}